French start-up develops new way of treating cancer

Antoine Prestat, CEO of PEP-Therapy, says his company can treat lung and ovarian cancers with molecules that “penetrate cells and act as a shuttle to deliver compounds that blocks specific pathological targets.”  Prestat pitched the idea at the 2015 ACES awards for academic enterprise in Barcelona.